Skip to main content
Displaying 2 of 2812 articles.

From the piano bench to the lab bench

Gabriel D. Victora is unlocking the mysteries of how the body generates antibodies to defend itself from pathogens. But there was a time when science was not even on his radar.

Promising new drug target for a rare liver cancer

Fibrolamellar carcinoma needs one specific mutation in order to thrive, and impeding it reduces tumor growth in mice.